Company Registration No. 07272954 (England and Wales)
Product Care Group Limited
Annual report and
group financial statements
for the 53 weeks ended 30 June 2024
Product Care Group Limited
Company information
Directors
J P Cohring
S Graham-Benson
L C Moore
S J Smith
R G Hodson
(Appointed 1 January 2025)
Company number
07272954
Registered office
Green Bank Business Park
Swan Lane
Hindley Green
Wigan
WN2 4AY
Independent auditor
Saffery LLP
Trinity
16 John Dalton Street
Manchester
M2 6HY
Product Care Group Limited
Contents
Page
Strategic report
1 - 4
Directors' report
5 - 7
Directors' responsibilities statement
8
Independent auditor's report
9 - 12
Group statement of comprehensive income
13
Group statement of financial position
14
Company statement of financial position
15
Group statement of changes in equity
16
Company statement of changes in equity
17
Group statement of cash flows
18
Notes to the financial statements
19 - 39
Product Care Group Limited
Strategic report
For the 53 weeks ended 30 June 2024
1

The directors present the strategic report for the 53 weeks ended 30 June 2024.

Review of the business

After a successful FY2023 the directors were confident that we could continue to achieve profitable sustainable growth and deliver our key strategic objectives in FY2024.  

CORE – Product Sales 

During the first half of the financial year (July to December) the business enjoyed some stable trading conditions.  Interest rates had peaked, the GBP/USD exchange rate settled, and freight rates returned to their pre-COVID levels. 

That stability, however, changed during Christmas & New Year 23/24. Houthi Rebels created a ‘no go zone’ in the Red Sea and forced container shipping to go instead, around the southern cape of Africa. This diversion initially caused disruption in stock availability, due to increased lead times. In addition, it also drove freight prices up significantly. Between December 23 and January 24 the China Containerized Freight Index doubled, it went on to double again by June 2024. 

Thankfully we did not suffer the full price impacts due to our freight risk mitigation strategy to forward contract our freight with key partners and the fantastic efforts of our UK and China colleagues.

I’m pleased to say our freight costs did not reflect that of the market, and along with further softening of the GBP/USD we were able to trade through the challenge without having to pass on cost increases to our customers. 

From a key category perspective, most moved forward, however, the MDA category suffered a sizeable double digit market decline for several months. Despite the market conditions, we outperformed the market by moving into new subcategories and opening up new routes to market. 

FLEET – Home deliveries 

FY2024 was a challenging year for the fleet, the largest cost element a home delivery service is labour and that had been driven up by UK wage inflation meaning costs had risen much faster than our sales prices, thus eroding margins. In addition to this, in the first half of the year we geared up (bought vans and hired people) for additional volume as promised by one of our strategic partners, but due to the decline in the aforementioned MDA market that volume didn’t materialise. It meant for several months we were carrying more overheads than we would have liked, and the fleet was reporting losses. 

We reviewed the fleet in detail and embarked on a turnaround plan, improved its efficiency and, worked with our partners to help ease some of the cost pressures. The result was that by the end of the financial year the fleet was back to being profitable. 

INTERNATIONAL

An encouraging year for our International business both in terms of performance and laying the foundations for growth going forward.

The EU and Australia are the main area of success, both presenting opportunities going into next year.

 

Product Care Group Limited
Strategic report (continued)
For the 53 weeks ended 30 June 2024
2
Fair review of the business (continued)

GROUP COMBINED 

The directors are pleased to report that FY2024 was a significant growth year and we report our highest ever turnover of £89.2m. This represents and YOY increase of 12.6%.  In addition to this, and despite a backdrop of high inflation we were also able to grow our PBT to £5.53m, which is a YOY increase of 27.6%. 

See the table below for a summary of the performance and our Key Performance indicators which are Turnover, Profit Before Tax and Net Debt. 

We have again demonstrated how resilient and strong we are as a Team and in our business performance. Positive foundations have been laid to ensure we convert the opportunities in the coming year.

The directors are very proud of the results in this financial year, and we’d like to record our thanks to all our Team for their valued contribution.  

 ACTUAL PERFORMANCE  

  

2024 

2023  

2022  

2021 

Turnover  

  89,263,697

79,258,825

  73,313,807

 78,149,241  

YOY Change  

12.62% 

8.11% 

-6.19% 

  

2 Year Change  

21.76% 

1.42% 

  

  

3 Year Change  

14.22% 

   

   

  

   

   

   

   

  

Profit Before tax  

5,523,352 

4,333,775 

4,500,955 

5,589,874 

YOY Change  

27.45% 

-3.71% 

19.48% 

  

2 Year Change  

22.72% 

-22.47% 

  

  

3 Year Change  

-1.19%

   

   

  

   

   

   

   

  

Cash/Net Debt  

-9,212,015 

-3,520,667 

-10,150,339 

-6,692,598 

YOY Change £  

-  5,691,348  

       6,629,672  

-   3,457,741  

  

2 year Change £  

          938,324  

       3,171,931  

  

  

3 Year Change £  

-      2,519,417  

   

   

  

 

At the balance sheet date, the Group had net assets of £4,673,983 (2023 - £7,385,218). The directors believe the Group’s balance sheet to be financially robust particularly given that net current assets were £4,353,452 (2023 - £6,285,454).

 

The directors believe that disclosing non-financial key performance indicators is not necessary for stakeholders to understand the group's development, performance, or position.

 

Product Care Group Limited
Strategic report (continued)
For the 53 weeks ended 30 June 2024
3
Principal risks and uncertainties

The principal risks and uncertainties facing the Group and the Group's steps to mitigate the risk are as follows:

 

Rising cost prices from our suppliers driven by increasing labour and raw materials costs

The directors manage this risk via strong sourcing capability, our China infrastructure and by maintaining strong long term relationships with factories and strategic partnerships with key suppliers.

 

Exposure to foreign currency fluctuations

The directors consistently monitor foreign currency markets and where possible will forward buy currency to ensure that as far as possible fluctuations have limited impact on the Groups’ trading results and cash flows.

 

Increased competition

The Group continues to refresh and develop its licensed core product ranges as well as investing in our own private label brands, entering new categories and channels and investing in sustainable retail relationships.

 

Over reliance on a single business factor

The directors are aware of the risk associated with over reliance on a single business factor, be that a single customer, supplier, geography, product category or brand. This risk is monitored regularly and considered in all new strategic decisions. Where possible steps are taken to diversify and mitigate any impact from this risk.

 

Hyper inflation

Whilst the ‘cost of living crisis’ is largely driven by events outside of the directors control the directors closely monitor its effects. Where possible, appropriate prices are locked to protect against inflation. Where cost increases, and therefore selling price increases cannot be avoided, the directors continuously look to drive efficiencies and reduce consumption to mitigate.

Section 172 statement

Employees

During the period under review, the Group employed an average of 241 employees (2023 : 213).

Our office-based colleagues continue to enjoy the flexibility of home working which has meant that the board and senior team put even more focus on regular communication updates on business performance and developments in order to keep teams well informed. The business has also invested in additional incentives and employee engagement activities throughout the year. Despite the challenges, we have continued to invest in training which has been remote where necessary. We have also provided resources to support colleagues with their mental health, including mental health first aiders and signposting of support material and services.

 

Environment and sustainability

The Group continues to work on its sustainability strategy which includes our commitment to reduce our ‘in scope’ carbon emissions by focussing on Product re-engineering, Home delivery efficiency and on-site operations, including recycling and energy saving initiatives. We have clear KPIs in place which are reviewed on a regular basis and work with accredited partners to ensure we are well informed and operating within regulatory parameters. We are working closely with our overseas factories to ensure they are aligned with our objectives.

Customers

The Group recognises that in today’s competitive market, success hinges on our customers being satisfied with both our product and service level. This applies to both our direct retailer customers and the end consumer. We strive to be flexible in our approach and to address each of our customers’ needs so that we can deliver the product and service they expect.

 

Suppliers

Management values its relationship with suppliers. We have a select panel and once onboarded the relationships usually last many years with a common goal for long term mutual success.

 

Product Care Group Limited
Strategic report (continued)
For the 53 weeks ended 30 June 2024
4
Section 172 statement (continued)

High standards and business conduct

The Group is committed to a core set of cultural values which are intrinsic to how we treat our people, our suppliers and our customers. This culture is also reflected in our recruitment process, our induction program and ongoing colleague training and engagement. We ensure that colleagues are aware of and receive periodic updates on our HR policies including areas such as Diversity, Bribery & Corruption and Pricing & Competition law.

 

Each year the board considers and approves our modern slavery statement demonstrating our commitment to seeking to ensure there is no slavery or forced labour or human trafficking within any part of our business or supply chains.

 

From a health and safety perspective we continue to invest in a dedicated team and systems which adhere to the requirements of ISO 45001 alongside a culture of complete transparency at all levels. Incident reporting is monitored closely and appropriate action taken. Overall, our incident and injury frequency rates per 100,000 hours are reducing at a sustainable pace, and colleagues are showing an improved level of involvement and ownership in relation to maintaining a low incident rate, and a higher than historical reporting rate. The Health and safety committee is key to this, as is the works being undertaken by the re-invigorated group of Employee Safety representatives.

 

The Group maintains a risk register which is the basis of our business continuity plan and is regularly reviewed. There is an audit and risk committee which convenes quarterly and reviews the outcome of any British Standard Institution (BSI) or internal audits and discusses strategy in the context of a ‘risk pipeline’.

 

The group are regularly audited by BSI in line with the following International Standards Organisation (ISO) accreditations which we hold:

 

ISO27001 Information Security Management

ISO45001 Health & Safety Management system

 

On behalf of the board

L C Moore
Director
31 January 2025
Product Care Group Limited
Directors' report
For the 53 weeks ended 30 June 2024
5

The directors present their annual report and financial statements for the 53 weeks ended 30 June 2024.

Principal activities

The principal activity of the Group continued to be the importation and distribution of own and licensed branded products as well offering specialist home delivery and associated services. The Group also operates a number of ecommerce retail platforms.

 

Product Care Group Limited has a principal activity of a holding company.

Results and dividends

The results for the 53 weeks are set out on page 13.

Ordinary dividends were paid amounting to £517,789. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the 53 weeks and up to the date of signature of the financial statements were as follows:

J P Cohring
S P Fisher
(Resigned 31 March 2024)
S Graham-Benson
G Hamer
(Resigned 31 March 2024)
L C Moore
S J Smith
D P Veevers
(Resigned 31 December 2024)
R G Hodson
(Appointed 1 January 2025)

Organisational structure

The Product Care Group is classified as a large unquoted company due to its size and shareholding structure.

 

Reporting period

The Product Care Group is reporting for the financial 53 weeks ended 30 June 2024.

 

Future developments

Since the balance sheet date, the Group has continued to perform well and despite the downturn in the UK economic outlook, rising costs driven by the recent government budget and strengthening USD we have been able to grow our revenues and expect FY2025 to be another strong year for Product Care Group.

 

Energy and carbon report

As the Group has consumed more than 40,000 kWh of energy in this reporting period, it is required to report on its emissions, energy consumption or energy efficiency activities.

 

Measurement methodology

Scope 1 and 2 consumption and CO₂e emission data has been calculated using the 2024 UK Government Conversion Factors for Company Reporting as made available at https://www.gov.uk/government/collections/government-conversion-factors-for-company-reporting

 

For properties where the Product Care Group is indirectly responsible for utilities (i.e. via a landlord or service charge), the Khw’s billed by the landlord has been used, or where a bill on account has been issued our own meter readings have been used to calculate the usage.

 

For our transport performance we have calculated the litres of diesel used by our delivery vans and inter-depot transport in the period by dividing the total spend by the average price per litre of the year.

Product Care Group Limited
Directors' report (continued)
For the 53 weeks ended 30 June 2024
6
2024
2023
Energy consumption
kWh
kWh
Aggregate of energy consumption in the year
- Gas combustion
271,857
225,255
- Electricity purchased
444,454
523,123
- Fuel consumed for transport
5,954,631
4,239,228
6,670,942
4,987,606
2024
2023
Emissions of CO2 equivalent
kg/CO2e
kg/CO2e
Scope 1 - direct emissions
- Gas combustion
52,879
41,418
- Fuel consumed for transport
1,421,329
1,072,635
1,474,208
1,114,053
Scope 2 - indirect emissions
- Electricity purchased
92,024
121,961
Total gross emissions
1,566,232
1,236,014
Intensity ratio
Kilograms of CO2e per £ of turnover
0.018
0.016
Kilograms of CO2e per employee
6,493
5,830
Kilograms of CO2e per delivery
9.538
9.031
Quantification and reporting methodology

The Group has followed the 2019 HM Government Environmental Reporting Guidelines. The Group has also used the GHG Reporting Protocol – Corporate Standard and have used the 2024 UK Government’s Conversion Factors for Company Reporting.

Intensity measurement

The chosen intensity measurement ratios are total gross emissions in kilograms of CO2e per £ of turnover and CO2e per employee. Furthermore, because the majority of the Group’s emissions arise from its home delivery network we also measure the CO2e per delivery. The turnover for FY2024 was £89,263,697 (2023 £79,258,825), the average number of employees for FY2024 was 241 (2023: 213).

Product Care Group Limited
Directors' report (continued)
For the 53 weeks ended 30 June 2024
7
Measures taken to improve energy efficiency

Our transport accounts for 91% (2023: 87%) of our calculated CO₂e. We continue to try and maximise the efficiency of our delivery miles. Such measures include training all technicians on how to drive in the most fuel-efficient way and maximising the payload per route. When it comes to transitioning to electric vehicles, management continue to monitor the technologies available regularly and will, when right for the group, consider making the change.

 

We have previously encouraged colleagues to take an all-electric or hybrid company car where possible however, and we continue with our strategy to move to an ‘all-electric’ only company car list which to date has been successful.

 

We continue to review how we hold stock across our sites and are beginning to hold stock in multiple locations to reduce the need for inter-depot transport.

 

Whilst not in the reportable scope, will are also looking to promote a reduction in carbon emissions by colleagues from home working and in their personal lives. Directly, this has been achieved by continuing to encourage remote working thus reducing the daily commute. Indirectly this involves us educating and informing our colleagues on small changes they can make to help reduce their personal carbon footprint. We also send out frequent updates in this regard, to improve employee engagement in our group carbon reduction strategy.

 

From a product sourcing perspective, we continue to work with our factories to reduce plastic in our packaging, move towards sustainable sources of paper and board and focus on recyclability targets all in line with our customer requirements.

 

The Product Care Group are not part of the Carbon Trust or any Carbon offset scheme, however the directors are in the process of reviewing this to see if it is appropriate for the Product Care Group to join such a scheme. We also work closely with our retailers in understanding their sustainability strategy and making relevant adjustments to meet their required standards.

 

Auditor                                

Saffery LLP have expressed their willingness to continue in office.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the Group is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the Group is aware of that information.

On behalf of the board

 

L C Moore
Director
31 January 2025
Product Care Group Limited
Directors' responsibilities statement
For the 53 weeks ended 30 June 2024
8

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Accounting Standards and applicable law (United Kingdom Generally Accepted Accounting Practice).

 

Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Group and Company, and of the profit or loss of the Group and Company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Product Care Group Limited
Independent auditor's report
To the members of Product Care Group Limited
9
Opinion

We have audited the financial statements of Product Care Group Limited (the 'Parent Company') and its subsidiaries (the 'Group') for the 53 weeks ended 30 June 2024 which comprise the Group statement of comprehensive income, the Group statement of financial position, the Company statement of financial position, the Group statement of changes in equity, the Company statement of changes in equity, the Group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Product Care Group Limited
Independent auditor's report (continued)
To the members of Product Care Group Limited
10

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the Group and the Parent Company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Product Care Group Limited
Independent auditor's report (continued)
To the members of Product Care Group Limited
11

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud are detailed below.

 

Identifying and assessing risks related to irregularities:

We assessed the susceptibility of the group and parent company’s financial statements to material misstatement and how fraud might occur, including through discussions with the directors, discussions within our audit team planning meeting, updating our record of internal controls and ensuring these controls operated as intended. We evaluated possible incentives and opportunities for fraudulent manipulation of the financial statements. We identified laws and regulations that are of significance in the context of the group and parent company by discussions with directors and by updating our understanding of the sector in which the group and parent company operates.

 

Laws and regulations of direct significance in the context of the group and parent company include The Companies Act 2006 and UK Tax legislation.

 

Audit response to risks identified

We considered the extent of compliance with these laws and regulations as part of our audit procedures on the related financial statement items including a review of Group and Parent Company financial statement disclosures. We reviewed the Parent Company's records of breaches of laws and regulations, minutes of meetings and correspondence with relevant authorities to identify potential material misstatements arising. We discussed the parent company's policies and procedures for compliance with laws and regulations with members of management responsible for compliance.

During the planning meeting with the audit team, the engagement partner drew attention to the key areas which might involve non-compliance with laws and regulations or fraud. We enquired of management whether they were aware of any instances of non-compliance with laws and regulations or knowledge of any actual, suspected or alleged fraud. We addressed the risk of fraud through management override of controls by testing the appropriateness of journal entries and identifying any significant transactions that were unusual or outside the normal course of business. We assessed whether judgements made in making accounting estimates gave rise to a possible indication of management bias. At the completion stage of the audit, the engagement partner’s review included ensuring that the team had approached their work with appropriate professional scepticism and thus the capacity to identify non-compliance with laws and regulations and fraud.

As group auditors, our assessment of matters relating to non-compliance with laws or regulations and fraud differed at group and component level according to their particular circumstances. Our communications included a request to identify instances of non-compliance with laws and regulations and fraud that could give rise to a material misstatement of the group financial statements in addition to our risk assessment.

 

There are inherent limitations in the audit procedures described above and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Product Care Group Limited
Independent auditor's report (continued)
To the members of Product Care Group Limited
12

Use of our report

This report is made solely to the parent company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the parent company's members those matters we are required to state to them in an auditors report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent company and the parent company's members as a body, for our audit work, for this report, or for the opinions we have formed.

 

Diane Petit-Laurent FCA (Senior Statutory Auditor)
For and on behalf of Saffery LLP
31 January 2025
Statutory Auditors
Trinity
16 John Dalton Street
Manchester
M2 6HY
Product Care Group Limited
Group statement of comprehensive income
For the 53 weeks ended 30 June 2024
13
53 weeks
52 weeks
ended
ended
30 June
25 June
2024
2023
Notes
£
£
Turnover
3
89,263,697
79,258,825
Cost of sales
(69,470,911)
(61,834,211)
Gross profit
19,792,786
17,424,614
Distribution costs
(666,433)
(674,559)
Administrative expenses
(13,909,312)
(11,374,472)
Other operating income
571,152
550,217
Operating profit
4
5,788,193
5,925,800
Interest payable and similar expenses
8
(875,798)
(565,561)
Other gains and losses
9
610,957
(1,026,464)
Profit before taxation
5,523,352
4,333,775
Tax on profit
10
(1,385,134)
(881,847)
Profit for the financial 53 weeks
25
4,138,218
3,451,928
Profit for the financial 53 weeks is all attributable to the owners of the parent company.
Total comprehensive income for the 53 weeks is all attributable to the owners of the parent company.
Product Care Group Limited
Group statement of financial position
As at 30 June 2024
14
30 June 2024
25 June 2023
Notes
£
£
£
£
Fixed assets
Intangible assets
12
3,318
63,180
Tangible assets
13
1,143,355
1,253,147
Investments
14
11,000
11,000
1,157,673
1,327,327
Current assets
Stocks
17
14,773,451
13,890,133
Debtors
18
19,522,895
15,750,707
Cash at bank and in hand
1,261,719
546,521
35,558,065
30,187,361
Creditors: amounts falling due within one year
19
(31,204,613)
(23,901,907)
Net current assets
4,353,452
6,285,454
Total assets less current liabilities
5,511,125
7,612,781
Creditors: amounts falling due after more than one year
20
(664,265)
-
Provisions for liabilities
Deferred tax liability
22
172,877
227,563
(172,877)
(227,563)
Net assets
4,673,983
7,385,218
Capital and reserves
Called up share capital
24
83,297
114,061
Share premium account
25
131,138
131,138
Capital redemption reserve
25
71,054
-
0
Other reserves
25
(6,420,493)
(6,420,493)
Profit and loss reserves
25
10,808,987
13,560,512
Total equity
4,673,983
7,385,218
The financial statements were approved by the board of directors and authorised for issue on 31 January 2025 and are signed on its behalf by:
31 January 2025
L C Moore
Director
Company registration number 07272954 (England and Wales)
Product Care Group Limited
Company statement of financial position
As at 30 June 2024
30 June 2024
15
30 June 2024
25 June 2023
Notes
£
£
£
£
Fixed assets
Intangible assets
12
-
0
58,180
Tangible assets
13
-
0
50,820
Investments
14
6,297,245
6,297,245
6,297,245
6,406,245
Current assets
Debtors
18
21,562
26,550
Cash at bank and in hand
23,492
16,268
45,054
42,818
Creditors: amounts falling due within one year
19
(5,525,784)
(5,624,488)
Net current liabilities
(5,480,730)
(5,581,670)
Total assets less current liabilities
816,515
824,575
Creditors: amounts falling due after more than one year
20
(536,014)
-
Provisions for liabilities
Deferred tax liability
22
-
0
10,116
-
(10,116)
Net assets
280,501
814,459
Capital and reserves
Called up share capital
24
83,297
114,061
Share premium account
25
131,138
131,138
Capital redemption reserve
25
71,054
-
0
Profit and loss reserves
25
(4,988)
569,260
Total equity
280,501
814,459

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £6,315,495 (2023 - £557,267 profit).

The financial statements were approved by the board of directors and authorised for issue on 31 January 2025 and are signed on its behalf by:
L C Moore
Director
Company Registration No. 07272954 (England and Wales)
Product Care Group Limited
Group statement of changes in equity
For the 53 weeks ended 30 June 2024
16
Share capital
Share premium account
Capital redemption reserve
Other reserves
Profit and loss reserves
Total
Notes
£
£
£
£
£
£
Balance at 27 June 2022
114,061
131,138
-
0
(6,420,493)
10,142,371
3,967,077
Period ended 25 June 2023:
Profit and total comprehensive income
-
-
-
-
3,451,928
3,451,928
Dividends
11
-
-
-
-
(33,787)
(33,787)
Balance at 25 June 2023
114,061
131,138
-
0
(6,420,493)
13,560,512
7,385,218
Period ended 30 June 2024:
Profit and total comprehensive income
-
-
-
-
4,138,218
4,138,218
Dividends
11
-
-
-
-
(517,789)
(517,789)
Redemption of shares
24
(30,764)
-
30,764
-
(6,331,664)
(6,331,664)
Other movements
-
-
40,290
-
(40,290)
-
Balance at 30 June 2024
83,297
131,138
71,054
(6,420,493)
10,808,987
4,673,983
Product Care Group Limited
Company statement of changes in equity
For the 53 weeks ended 30 June 2024
17
Share capital
Share premium account
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 27 June 2022
114,061
131,138
-
45,780
290,979
Period ended 25 June 2023:
Profit and total comprehensive income for the period
-
-
-
557,267
557,267
Dividends
11
-
-
-
(33,787)
(33,787)
Balance at 25 June 2023
114,061
131,138
-
0
569,260
814,459
Period ended 30 June 2024:
Profit and total comprehensive income
-
-
-
6,315,495
6,315,495
Dividends
11
-
-
-
(517,789)
(517,789)
Redemption of shares
24
(30,764)
-
30,764
(6,331,664)
(6,331,664)
Other movements
-
-
40,290
(40,290)
-
Balance at 30 June 2024
83,297
131,138
71,054
(4,988)
280,501
Product Care Group Limited
Group statement of cash flows
For the 53 weeks ended 30 June 2024
18
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
32
3,655,916
6,987,219
Interest paid
(875,798)
(565,561)
Income taxes paid
(807,684)
(1,131,558)
Net cash inflow from operating activities
1,972,434
5,290,100
Investing activities
Purchase of intangible assets
-
(6,400)
Proceeds from disposal of intangibles
-
1,400
Purchase of tangible fixed assets
(277,056)
(838,135)
Proceeds from disposal of tangible fixed assets
204,520
49,624
Net cash used in investing activities
(72,536)
(793,511)
Financing activities
Redemption of shares
(6,331,664)
-
0
Proceeds from borrowings
2,691,072
-
Proceeds from new bank loans
4,113,329
-
Repayment of bank loans
(934,780)
(6,112,914)
Payment of finance leases obligations
(204,868)
(21,097)
Dividends paid to equity shareholders
(517,789)
(33,787)
Net cash used in financing activities
(1,184,700)
(6,167,798)
Net increase/(decrease) in cash and cash equivalents
715,198
(1,671,209)
Cash and cash equivalents at beginning of 53 weeks
546,521
2,217,730
Cash and cash equivalents at end of 53 weeks
1,261,719
546,521
Product Care Group Limited
Notes to the group financial statements
For the 53 weeks ended 30 June 2024
19
1
Accounting policies
Company information

Product Care Group Limited (“the company”) is a private company limited by shares incorporated in England and Wales. The registered office is Green Bank Business Park, Swan Lane, Hindley Green, Wigan, WN2 4AY.

 

The Group consists of Product Care Group Limited and all of its subsidiaries. PCT Foshan has been excluded from consolidation as its inclusion is not material for the purposes of giving a true and fair view.

 

The Company's and the Group's principal activities and nature of its operations are disclosed in the Directors' report.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006. Including the provisions of the Large and Medium Sized Companies and Groups (Accounts and Reports) Regulations 2008.

 

These accounts have been prepared for the 53 week period ended 30 June 2024. The prior period was for the 52 week period ended 25 June 2023.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

 

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
1
Accounting policies (continued)
20
1.2
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the Parent Company Product Care Group Limited together with all entities controlled by the Parent Company (its subsidiaries) and the Group’s share of its interests in joint ventures and associates.

 

All financial statements are made up to 30 June 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the Group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

 

The cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill.

 

The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date.

Subsidiaries are consolidated in the Group's financial statements from the date that control commences until the date that control ceases.

1.3
Going concern

These financial statements have been prepared on a going concern basis.

 

The directors have prepared cash flow projections for the Company and its Group and revised these in light of the current trading outlook. Within these projections they have considered a range of possible scenarios for the foreseeable future, including adverse foreign exchange and freight rate movements. The projections cover a period of at least 12 months from the date of signature of the financial statements. After considering the strength of the Company and Group balance sheet, along with the current year trading performance verses those projections, the directors consider the Company and its group to be well placed to sustain the impact of any potential downturn in trade.

 

1.4
Turnover

Turnover represents the amounts receivable for goods and services net of VAT and trade discounts. Sales are recognised at the point at which the group has transferred the risk and rewards to the customer.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Turnover relating to services is recognised at the point at which the group has fulfilled its contractual obligations and the risks and rewards attaching to the service and products have been transferred to the customer.

 

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
1
Accounting policies (continued)
21
1.5
Intangible fixed assets other than goodwill

Intangible fixed assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible fixed assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
20% - 33% straight line
Trademarks
10% straight line

Some trademarks are determined to have an indefinite useful life and are not amortised, but instead reviewed for impairment annually, or more often if an indication of impairment arises.

1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
10% - 33% straight line
Plant and machinery
10% - 50% straight line
Fixtures, fittings and equipment
10% - 33% straight line
New motor vehicles
33% straight line (£1,000 residual value assumption)
Used motor vehicles
50% straight line (£1,000 residual value assumption)

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the income statement.

1.7
Fixed asset investments

In the separate accounts of the company, interests in subsidiaries are initially measured at cost.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.8
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
1
Accounting policies (continued)
22
1.9
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.10
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.11
Financial instruments

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the group's statement of financial position when the group becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
1
Accounting policies (continued)
23
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

1.12
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.13
Taxation

The tax expense represents the sum of the current tax expense and deferred tax expense. Current tax assets are recognised when tax paid exceeds the tax payable.

 

Current and deferred tax is charged or credited to profit or loss, except when it relates to items charged or credited to other comprehensive income or equity, when the tax follows the transaction or event it relates to and is also charged or credited to other comprehensive income, or equity.

 

Current tax assets and current tax liabilities and deferred tax assets and deferred tax liabilities are offset, if and only if, there is a legally enforceable right to set off the amounts and the entity intends either to settle on the net basis or to realise the asset and settle the liability simultaneously.

 

Current tax is based on taxable profit for the year. Current tax assets and liabilities are measured using tax rates that have been enacted or substantively enacted by the reporting date.

 

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, where transactions of events that result in an obligation to pay more or a right to pay less tax in the future have occurred by the balance sheet date with certain limited exceptions.

 

Deferred tax is calculated on an undiscounted basis at the tax rates that are expected to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
1
Accounting policies (continued)
24
1.14
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.15
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.16
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

1.17
Foreign exchange

Transactions in foreign currencies are translated into the Group's functional currency (GBP) using a budgeted rate of exchange that prevailed at the date of the transaction. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

1.18

Warranty obligations

When turnover is recognised for the sale of electronic goods, a provision is made for the estimated costs of the warranty obligation. The provision is measured based on the probability weighting of all possible outcomes.

2
Critical accounting judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

Critical judgements

The directors do not consider there to be any critical judgements.

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
2
Critical accounting judgements and key sources of estimation uncertainty (continued)
25
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows:

Warranty provision

The directors make a provision for the estimated cost of warranty and servicing on the sale of electronic goods. These provisions require management's best estimate of the costs that will be incurred based on the probability weighting of all possible outcomes. Including an assessment of historical rates of return and products sold in the year. The provision held at the year end was £2,202,665 (2023: £2,285,124).

Stock provision

The group considers whether stocks are impaired. The directors review stock on a line by line basis and stocks identified as having no or nominal consideration are measured at the lower of cost and net realisable value, adjusted where applicable for any loss of services potential. The provision for impairment of stock recognised is £570,155 (2023: £437,760) which is due to slow moving and obsolete stock.

Accruals

The directors estimate the rebates due to be paid to retailers selling products on behalf of the group. The accrual is calculated based on the underlying contractual terms that the group trades with the retailers. The amount accrued for in relation to rebates due to retailers is £623,779 (2023: £926,736).

Depreciation

During the year, the directors reviewed and amended the Motor Vehicle depreciation. The review resulted in reduction of both the residual value and useful life of the vehicles which was a fair reflection following a significant increase in the number of miles the vehicles do. The change resulted in an additional depreciation charge for FY2024 of £187,000 when compared to the previous accounting estimate.

3
Turnover and other revenue
2024
2023
£
£
Turnover analysed by class of business
Goods
83,785,283
75,456,139
Services
5,478,414
3,802,686
89,263,697
79,258,825
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
88,583,588
79,003,687
Europe
338,779
184,820
Rest of world
341,330
70,318
89,263,697
79,258,825
Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
3
Turnover and other revenue (continued)
26
2024
2023
£
£
Other revenue
Sundry income
571,152
550,217
4
Operating profit
2024
2023
£
£
Operating profit for the period is stated after charging/(crediting):
Exchange gains
(718,174)
(948,593)
Depreciation of owned tangible fixed assets
612,057
483,104
Depreciation of tangible fixed assets held under finance leases
267,345
-
Loss on disposal of tangible fixed assets
44,719
39,428
Amortisation of intangible assets
59,862
-
Operating lease charges
1,414,465
1,311,566
5
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
13,810
13,250
Audit of the financial statements of the company's subsidiaries
36,490
35,000
50,300
48,250
For other services
Taxation compliance services
10,957
13,700
All other non-audit services
9,603
10,560
20,560
24,260
Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
27
6
Employees

The average monthly number of persons (including directors) employed by the Group and Company during the 53 weeks was:

Group
Company
2024
2023
2024
2023
Number
Number
Number
Number
Warehouse staff
41
39
-
-
Delivery technicians
76
51
-
-
Administrative staff
117
117
-
-
Directors
7
6
5
6
Total
241
213
5
6

Their aggregate remuneration comprised:

Group
Company
2024
2023
2024
2023
£
£
£
£
Wages and salaries
9,903,566
7,959,684
700,738
669,395
Social security costs
929,407
739,923
83,012
78,797
Pension costs
508,761
401,022
102,974
81,394
11,341,734
9,100,629
886,724
829,586
7
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
604,791
577,220
Amounts receivable under long term incentive schemes
10,350
6,907
Company pension contributions to defined contribution schemes
101,765
76,111
716,906
653,331
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 5 (2023 - 6).
Remuneration disclosed above includes the following amounts paid to the highest paid director:
2024
2023
£
£
Remuneration for qualifying services
187,885
167,449
Company pension contributions to defined contribution schemes
20,245
18,736
Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
28
8
Interest payable and similar expenses
2024
2023
£
£
Interest on bank overdrafts and loans
851,237
543,493
Other interest on financial liabilities
5,210
4,123
Interest on finance leases and hire purchase contracts
19,273
17,933
Other interest
78
12
Total finance costs
875,798
565,561
9
Other gains and losses
2024
2023
£
£
Fair value gains/(losses) on financial instruments
Gain/(loss) on financial liabilities held at fair value through profit or loss
610,957
(1,026,464)
10
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
1,427,081
768,463
Adjustments in respect of prior periods
12,739
146
Total current tax
1,439,820
768,609
Deferred tax
Origination and reversal of timing differences
(29,290)
110,672
Adjustment in respect of prior periods
(25,396)
2,566
Total deferred tax
(54,686)
113,238
Total tax charge
1,385,134
881,847
Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
10
Taxation (continued)
29

The actual charge for the 53 weeks can be reconciled to the expected charge for the 53 weeks based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit before taxation
5,523,352
4,333,775
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 20.50%)
1,380,838
884,621
Tax effect of expenses that are not deductible in determining taxable profit
14,204
3,649
Permanent capital allowances in excess of depreciation
-
(28,207)
Depreciation on assets not qualifying for tax allowances
2,830
-
Other permanent differences
-
0
283
Under/(over) provided in prior years
12,739
146
Deferred tax adjustments in respect of prior years
(25,396)
1,169
Tax at marginal rate
(81)
-
0
Effect of change in deferred tax rate
-
0
20,186
Taxation charge
1,385,134
881,847
11
Dividends
2024
2023
Recognised as distributions to equity holders:
£
£
Final paid
517,789
33,787
Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
30
12
Intangible fixed assets
Group
Software
Trademarks
Total
£
£
£
Cost
At 26 June 2023
352,546
58,180
410,726
Disposals
(39,650)
-
0
(39,650)
At 30 June 2024
312,896
58,180
371,076
Amortisation and impairment
At 26 June 2023
347,546
-
0
347,546
Amortisation charged for the 53 weeks
1,682
58,180
59,862
Disposals
(39,650)
-
0
(39,650)
At 30 June 2024
309,578
58,180
367,758
Carrying amount
At 30 June 2024
3,318
-
0
3,318
At 25 June 2023
5,000
58,180
63,180
Company
Trademarks
£
Cost
At 26 June 2023 and 30 June 2024
58,180
Amortisation and impairment
At 26 June 2023
-
0
Amortisation charged for the 53 weeks
58,180
At 30 June 2024
58,180
Carrying amount
At 30 June 2024
-
0
At 25 June 2023
58,180
Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
31
13
Tangible fixed assets
Group
Leasehold improvements
Plant and machinery
Fixtures, fittings and equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 26 June 2023
323,371
260,459
588,786
1,353,429
2,526,045
Additions
9,572
58,190
5,159
945,928
1,018,849
Disposals
-
0
-
0
-
0
(734,061)
(734,061)
At 30 June 2024
332,943
318,649
593,945
1,565,296
2,810,833
Depreciation and impairment
At 26 June 2023
127,655
163,518
441,777
539,948
1,272,898
Depreciation charged in the 53 weeks
51,986
63,423
42,431
721,562
879,402
Eliminated in respect of disposals
-
0
-
0
-
0
(484,822)
(484,822)
At 30 June 2024
179,641
226,941
484,208
776,688
1,667,478
Carrying amount
At 30 June 2024
153,302
91,708
109,737
788,608
1,143,355
At 25 June 2023
195,716
96,941
147,009
813,481
1,253,147
Company
Motor vehicles
£
Cost
At 26 June 2023
143,933
Disposals
(122,234)
At 30 June 2024
21,699
Depreciation and impairment
At 26 June 2023
93,113
Depreciation charged in the 53 weeks
1,256
Eliminated in respect of disposals
(72,670)
At 30 June 2024
21,699
Carrying amount
At 30 June 2024
-
0
At 25 June 2023
50,820
Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
13
Tangible fixed assets (continued)
32

The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.

Group
Company
2024
2023
2024
2023
£
£
£
£
Motor vehicles
474,448
-
0
-
0
-
0
14
Fixed asset investments
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Investments in subsidiaries
15
11,000
11,000
6,297,245
6,297,245
Movements in fixed asset investments
Group
Shares in subsidiaries
£
Cost or valuation
At 26 June 2023 and 30 June 2024
11,000
Carrying amount
At 30 June 2024
11,000
At 25 June 2023
11,000
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 26 June 2023 and 30 June 2024
6,297,245
Carrying amount
At 30 June 2024
6,297,245
At 25 June 2023
6,297,245
Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
33
15
Subsidiaries

Details of the company's subsidiaries at 30 June 2024 are as follows:

Name of undertaking
Address
Nature of business
Class of
% Held
shares held
Direct
Indirect
Product Care Hub Limited
1
Group services
Ordinary
100.00
-
Product Care Services Limited
1
Home delivery, product servicing and customer service helpline.
Ordinary
100.00
-
Product Care Trading Limited
1
Sales of products in the home appliance sector.
Ordinary
100.00
-
Product Care Online Limited
1
Sales of household appliances through online marketplaces.
Ordinary
100.00
-
Pricetag Limited
1
Dormant company
Ordinary
100.00
-
PCT Foshan
2
China office
Ordinary
-
100.00
PCT (NI) Limited
3
Dormant company
Ordinary
-
100.00
Emanate Trading Limited
1
Dormant company
Ordinary
100.00
-
White Goods Distribution Services Limited
1
Dormant company
Ordinary
100.00
-
Electrical Shop Ltd
1
Dormant company
Ordinary
100.00
-
Matchstick Men Limited
1
Dormant company
Ordinary
100.00
-
G2S Limited
1
Dormant company
Ordinary
100.00
-
Product Care Limited
1
Dormant company
Ordinary
100.00
-
Design and Trade Limited
1
Dormant company
Ordinary
100.00
-
Matchstick Men Hub Limited
1
Dormant company
Ordinary
100.00
-

Registered office addresses (all UK unless otherwise indicated):

1
Green Bank Business Park, Swan Lane, Hindley Green, Wigan, England, WN2 4AY
2
Forshan City, Guandong, China
3
Unit 121, Moat House, 54 Bloomfield Avenue, Belfast, County Antrim, United Kingdom BT5 5AD

PCT Foshan has not been consolidated as its inclusion is not material for the purpose of giving a true and fair view.

16
Financial instruments
Group
Company
2024
2023
2024
2023
£
£
£
£
Carrying amount of financial liabilities
Measured at fair value through profit or loss
- Other financial liabilities
51,739
662,696
-
-
Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
16
Financial instruments (continued)
34

The Group mitigates it's foreign exchange risk by entering into forward currency contracts. At 30 June 2024, the outstanding contracts all mature within 18 months of the year end. At the year end the Group had committed to buy $29.125m (2023 - $29.25m) and Nil (2023 - Nil) over the next 18 months, with a variable liability at the maturity rate. The forward currency contacts are measured at fair value using the exchange rates for GBP:USD/EUR. The fair value of the contracts is a liability of £51,739 (2023: a liability of £662,696).

 

17
Stocks
Group
Company
2024
2023
2024
2023
£
£
£
£
Finished goods and goods for resale
14,773,451
13,890,133
-
0
-
0

The provision for impairment of stock recognised is £570,155 (2023: £437,760) which is due to slow moving and obsolete stock.

18
Debtors
Group
Company
2024
2023
2024
2023
Amounts falling due within one year:
£
£
£
£
Trade debtors
17,544,376
14,424,568
-
0
-
0
Corporation tax recoverable
-
0
1,123
-
0
-
0
Other debtors
26,480
41,550
328
328
Prepayments and accrued income
1,952,039
1,283,466
16,522
26,222
19,522,895
15,750,707
16,850
26,550
Amounts falling due after more than one year:
Deferred tax asset (note 22)
-
0
-
0
4,712
-
0
Total debtors
19,522,895
15,750,707
21,562
26,550

Included in trade debtors is a provision for bad debts of £19,880 (2023: £36,686).

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
35
19
Creditors: amounts falling due within one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Bank loans
21
6,018,833
3,376,298
1,529,206
-
0
Obligations under finance leases
408,674
-
0
-
0
-
0
Invoice discounting
21
3,381,962
690,890
-
0
-
0
Trade creditors
11,886,314
9,728,023
36,962
3,051
Amounts owed to group undertakings
-
0
-
0
2,295,387
3,553,312
Corporation tax payable
763,728
132,715
59,426
12,943
Other taxation and social security
1,907,842
2,215,329
1,454,520
1,938,853
Derivative financial instruments
51,739
662,696
-
0
-
0
Other creditors
2,935,311
3,795,379
12,394
36,162
Accruals and deferred income
3,850,210
3,300,577
137,889
80,167
31,204,613
23,901,907
5,525,784
5,624,488

Included in other borrowings is £3,381,962 (2023: £690,890) in relation to an invoice discounting facility, secured by a fixed charge over debtors and floating charge over all other assets in the Group.

20
Creditors: amounts falling due after more than one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Bank loans and overdrafts
21
536,014
-
0
536,014
-
0
Obligations under finance leases
128,251
-
0
-
0
-
0
664,265
-
536,014
-
21
Loans and overdrafts
Group
Company
2024
2023
2024
2023
£
£
£
£
Bank loans
6,554,847
3,376,298
2,065,220
-
0
Other loans
3,381,962
690,890
-
0
-
0
9,936,809
4,067,188
2,065,220
-
Payable within one year
9,400,795
4,067,188
1,529,206
-
0
Payable after one year
536,014
-
0
536,014
-
0

The bank loans are secured by a fixed and floating charge over all the assets and undertakings of the Group.

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
21
Loans and overdrafts (continued)
36

The maximum import loan term is 120 days, and the interest rates on these loans are variable tracking the currency's base rate. At the year end the rates were 5.375% for USD and 5.25% for GBP.

 

There is a fixed and floating charge held over all of the Group assets dated 25 January 2019, given by HSBC UK Bank Plc.

22
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the Group and Company, and movements thereon:

Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Group
£
£
£
£
Accelerated capital allowances
220,222
223,560
-
-
Short term timing differences
(47,345)
4,003
-
-
172,877
227,563
-
-
Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Company
£
£
£
£
Accelerated capital allowances
-
12,705
-
-
Short term timing differences
-
(2,589)
4,712
-
-
10,116
4,712
-
Group
Company
2024
2024
Movements in the 53 weeks:
£
£
Liability at 26 June 2023
227,563
10,116
Credit to profit or loss
(54,686)
(14,828)
Liability/(Asset) at 30 June 2024
172,877
(4,712)

The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
37
23
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
508,761
401,022

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the Group in an independently administered fund.

 

Included in creditors at the year end is £98,278 (2023: £68,145) payable to the scheme.

24
Share capital
Group and company
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of £1 each
53,484
72,913
53,484
72,913
Ordinary B shares of £1 each
29,813
41,148
29,813
41,148
83,297
114,061
83,297
114,061

Ordinary A shares carry voting, dividend and rights in respect of the distribution of capital.

 

Ordinary B shares carry dividend and rights in respect of the distribution of capital, but have no voting rights.

 

On 5 October 2023, the company purchased and cancelled 19,429 Ordinary A and 11,335 Ordinary B shares for consideration of £6,300,160.

25
Reserves
Share premium

The share premium reserve is consideration received for shares issued above their nominal value net of transaction costs.

Equity reserve

Cumulative profit and loss net of distributions to owners.

Capital redemption reserve

The capital redemption reserve represents a non-distributable reserve amounting to the the nominal value of the shares repurchased by the company.

Other reserves

The other reserve is a merger reserve.

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
38
26
Financial commitments, guarantees and contingent liabilities

There was a guarantee date 1 February 2019 in favour of HM Revenue and Customs for £Nil (2023: £Nil).

 

There is a fixed and floating charge held over all of the company assets date 25 January 2019, given by HSBC UK Bank PLC.

27
Operating lease commitments
Lessee

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Company
2024
2023
2024
2023
£
£
£
£
Within one year
1,341,077
1,386,048
-
-
Between two and five years
2,171,494
3,302,609
-
-
3,512,571
4,688,657
-
-
28
Events after the reporting date

On 21 August 2024, 833 Ordinary A shares with the designation A1 were re-designated to A7. Their share class was unaffected.

29
Related party transactions
Remuneration of key management personnel

The remuneration of key management personnel is as follows.

2024
2023
£
£
Aggregate compensation
1,928,624
1,767,021

Other information

Included in creditors at the year end is £Nil (2023: £20,000) owed to a company related by common control.

30
Directors' transactions

Dividends totalling £193,347 (2023: £12,617) were paid in the 53 weeks in respect of shares held by the company's directors.

Product Care Group Limited
Notes to the group financial statements (continued)
For the 53 weeks ended 30 June 2024
39
31
Controlling party

The directors consider the intermediate parent company to be Hamer Capital Ventures Limited, a company registered in England and Wales. Hamer Capital Ventures Limited prepares group accounts which include this company. Copies of the accounts can be obtained from Companies House, Crown Way, Cardiff, CF4 3UZ.

 

Hamer Capital Ventures Limited is a company owned and controlled by the Hamer family.

 

32
Cash generated from group operations
2024
2023
£
£
Profit for the 53 weeks after tax
4,138,218
3,451,928
Adjustments for:
Taxation charged
1,385,134
881,847
Finance costs
875,798
565,561
Loss on disposal of tangible fixed assets
44,719
39,428
Amortisation and impairment of intangible assets
59,862
-
Depreciation and impairment of tangible fixed assets
879,402
483,104
Other gains and losses
(610,957)
1,026,464
Movements in working capital:
(Increase)/decrease in stocks
(883,318)
2,675,334
Increase in debtors
(3,773,311)
(2,217,116)
Increase in creditors
1,540,369
80,669
Cash generated from operations
3,655,916
6,987,219
33
Analysis of changes in net debt - group
26 June 2023
Cash flows
New finance leases
Market value movements
30 June 2024
£
£
£
£
£
Cash at bank and in hand
546,521
715,198
-
-
1,261,719
Borrowings excluding overdrafts
(4,067,188)
(6,480,578)
-
610,957
(9,936,809)
Obligations under finance leases
-
204,868
(741,793)
-
(536,925)
(3,520,667)
(5,560,512)
(741,793)
610,957
(9,212,015)
2024-06-302023-06-26falseCCH SoftwareCCH Accounts Production 2024.210J P CohringS P FisherS Graham-BensonG HamerL C MooreS J SmithD P VeeversRichard HodsonR G Hodsonfalsefalse072729542023-06-262024-06-3007272954bus:Director12023-06-262024-06-3007272954bus:Director32023-06-262024-06-3007272954bus:Director52023-06-262024-06-3007272954bus:Director62023-06-262024-06-3007272954bus:Director92023-06-262024-06-3007272954bus:Director22023-06-262024-06-3007272954bus:Director42023-06-262024-06-3007272954bus:Director72023-06-262024-06-3007272954bus:Director82023-06-262024-06-3007272954bus:RegisteredOffice2023-06-262024-06-3007272954core:CapitalRedemptionReserve2022-06-2607272954core:OtherMiscellaneousReserve2022-06-2607272954core:ShareCapitalbus:Consolidated2024-06-3007272954core:ShareCapitalbus:Consolidated2023-06-2507272954core:SharePremiumbus:Consolidated2024-06-3007272954core:SharePremiumbus:Consolidated2023-06-2507272954core:CapitalRedemptionReservebus:Consolidated2024-06-3007272954core:CapitalRedemptionReservebus:Consolidated2023-06-2507272954core:OtherMiscellaneousReservebus:Consolidated2024-06-3007272954core:OtherMiscellaneousReservebus:Consolidated2023-06-2507272954core:ShareCapital2024-06-3007272954core:ShareCapital2023-06-2507272954core:SharePremium2024-06-3007272954core:SharePremium2023-06-2507272954core:CapitalRedemptionReserve2024-06-3007272954core:CapitalRedemptionReserve2023-06-2507272954core:RetainedEarningsAccumulatedLosses2024-06-3007272954core:ShareCapitalbus:Consolidated2022-06-2607272954core:SharePremiumbus:Consolidated2022-06-2607272954core:CapitalRedemptionReservebus:Consolidated2022-06-2607272954core:RetainedEarningsAccumulatedLossesbus:Consolidated2022-06-2607272954core:RetainedEarningsAccumulatedLossesbus:Consolidated2023-06-2507272954core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-06-3007272954core:ShareCapital2022-06-2607272954core:SharePremium2022-06-2607272954core:RetainedEarningsAccumulatedLosses2022-06-2607272954core:RetainedEarningsAccumulatedLosses2023-06-25072729542024-06-3007272954bus:Consolidated2024-06-3007272954bus:Consolidated2023-06-262024-06-3007272954bus:Consolidated2022-06-272023-06-25072729542022-06-272023-06-2507272954core:OtherResidualIntangibleAssetsbus:Consolidated2024-06-3007272954core:OtherResidualIntangibleAssetsbus:Consolidated2023-06-2507272954core:OtherResidualIntangibleAssets2024-06-3007272954core:OtherResidualIntangibleAssets2023-06-2507272954core:ComputerSoftwarebus:Consolidated2024-06-3007272954core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2024-06-3007272954core:ComputerSoftwarebus:Consolidated2023-06-2507272954core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2023-06-2507272954bus:Consolidated2023-06-2507272954core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-06-3007272954core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2023-06-25072729542023-06-2507272954core:LeaseholdImprovementsbus:Consolidated2024-06-3007272954core:PlantMachinerybus:Consolidated2024-06-3007272954core:FurnitureFittingsbus:Consolidated2024-06-3007272954core:MotorVehiclesbus:Consolidated2024-06-3007272954core:LeaseholdImprovementsbus:Consolidated2023-06-2507272954core:PlantMachinerybus:Consolidated2023-06-2507272954core:FurnitureFittingsbus:Consolidated2023-06-2507272954core:MotorVehiclesbus:Consolidated2023-06-2507272954core:MotorVehicles2024-06-3007272954core:MotorVehicles2023-06-2507272954bus:Consolidated2022-06-2607272954core:IntangibleAssetsOtherThanGoodwill2023-06-262024-06-3007272954core:ComputerSoftware2023-06-262024-06-3007272954core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2023-06-262024-06-3007272954core:LeaseholdImprovements2023-06-262024-06-3007272954core:PlantMachinery2023-06-262024-06-3007272954core:FurnitureFittings2023-06-262024-06-3007272954core:MotorVehicles2023-06-262024-06-3007272954core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2023-06-262024-06-3007272954core:UKTaxbus:Consolidated2023-06-262024-06-3007272954core:UKTaxbus:Consolidated2022-06-272023-06-2507272954bus:Consolidated12023-06-262024-06-3007272954bus:Consolidated12022-06-272023-06-2507272954bus:Consolidated22023-06-262024-06-3007272954bus:Consolidated22022-06-272023-06-2507272954bus:Consolidated32023-06-262024-06-3007272954bus:Consolidated32022-06-272023-06-2507272954bus:Consolidated42023-06-262024-06-3007272954bus:Consolidated42022-06-272023-06-2507272954core:ComputerSoftwarebus:Consolidated2023-06-2507272954core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2023-06-2507272954bus:Consolidated2023-06-2507272954core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2023-06-2507272954core:ComputerSoftwarebus:Consolidated2023-06-262024-06-3007272954core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwillbus:Consolidated2023-06-262024-06-3007272954core:LeaseholdImprovementsbus:Consolidated2023-06-2507272954core:PlantMachinerybus:Consolidated2023-06-2507272954core:FurnitureFittingsbus:Consolidated2023-06-2507272954core:MotorVehiclesbus:Consolidated2023-06-2507272954core:MotorVehicles2023-06-2507272954core:LeaseholdImprovementsbus:Consolidated2023-06-262024-06-3007272954core:PlantMachinerybus:Consolidated2023-06-262024-06-3007272954core:FurnitureFittingsbus:Consolidated2023-06-262024-06-3007272954core:MotorVehiclesbus:Consolidated2023-06-262024-06-3007272954core:CurrentFinancialInstruments2024-06-3007272954core:CurrentFinancialInstruments2023-06-2507272954core:CurrentFinancialInstrumentsbus:Consolidated2024-06-3007272954core:CurrentFinancialInstrumentsbus:Consolidated2023-06-2507272954core:Non-currentFinancialInstrumentsbus:Consolidated2024-06-3007272954core:Non-currentFinancialInstrumentsbus:Consolidated2023-06-2507272954core:Non-currentFinancialInstruments2024-06-3007272954core:Non-currentFinancialInstruments2023-06-2507272954core:WithinOneYearbus:Consolidated2024-06-3007272954core:WithinOneYearbus:Consolidated2023-06-2507272954core:CurrentFinancialInstrumentscore:WithinOneYear2024-06-3007272954core:CurrentFinancialInstrumentscore:WithinOneYear2023-06-2507272954core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-06-3007272954core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2023-06-2507272954core:Non-currentFinancialInstrumentscore:AfterOneYear2024-06-3007272954core:Non-currentFinancialInstrumentscore:AfterOneYear2023-06-2507272954core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-06-3007272954core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2023-06-2507272954bus:PrivateLimitedCompanyLtd2023-06-262024-06-3007272954bus:FRS1022023-06-262024-06-3007272954bus:Audited2023-06-262024-06-3007272954bus:ConsolidatedGroupCompanyAccounts2023-06-262024-06-3007272954bus:FullAccounts2023-06-262024-06-30xbrli:purexbrli:sharesiso4217:GBP